Literature DB >> 12213469

Highly-iodinated fullerene as a contrast agent for X-ray imaging.

Tim Wharton1, Lon J Wilson.   

Abstract

The first fullerene-based X-ray contrast agent (CA) has been designed, synthesized, and characterized. The new CA is an externally functionalized derivative of C60 that is conceptually based on contemporary X-ray CA, all of which use iodine as the X-ray attenuating vehicle and are based on the 2,4,6-triiodinated-benzene-ring substructure. Using a modified Bingel-type reaction, a single addend containing 6 iodine atoms and 8 protected hydroxyl groups was appended to C60 followed by the addition of 4 more addends each containing 4 protected hydroxyl groups. Final deprotection afforded the highly water-soluble (>460 mg/mL), non-ionic, highly-iodinated (24% I) fullerene for application as an X-ray contrast agent.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12213469     DOI: 10.1016/s0968-0896(02)00252-3

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  16 in total

1.  Internalization of C60 fullerenes into cancer cells with accumulation in the nucleus via the nuclear pore complex.

Authors:  Mustafa Raoof; Yuri Mackeyev; Matthew A Cheney; Lon J Wilson; Steven A Curley
Journal:  Biomaterials       Date:  2012-01-14       Impact factor: 12.479

2.  Antimicrobial Photodynamic Therapy with Functionalized Fullerenes: Quantitative Structure-activity Relationships.

Authors:  Kazue Mizuno; Timur Zhiyentayev; Liyi Huang; Sarwat Khalil; Faria Nasim; George P Tegos; Hariprasad Gali; Ashlee Jahnke; Tim Wharton; Michael R Hamblin
Journal:  J Nanomed Nanotechnol       Date:  2011-04-01

3.  Cationic fullerenes are effective and selective antimicrobial photosensitizers.

Authors:  George P Tegos; Tatiana N Demidova; Dennisse Arcila-Lopez; Haeryeon Lee; Tim Wharton; Hariprasad Gali; Michael R Hamblin
Journal:  Chem Biol       Date:  2005-10

4.  Cell Internalization Studies of Gadofullerene-(ZME-018) Immunoconjugates into A375m Melanoma Cells.

Authors:  Christopher Scott Berger; John W Marks; Robert D Bolskar; Michael G Rosenblum; Lon J Wilson
Journal:  Transl Oncol       Date:  2011-12-01       Impact factor: 4.243

5.  The influence of cell and nanoparticle properties on heating and cell death in a radiofrequency field.

Authors:  Yuri Mackeyev; Colette Mark; Natasha Kumar; Rita E Serda
Journal:  Acta Biomater       Date:  2017-02-05       Impact factor: 8.947

6.  Destroying gadofullerene aggregates by salt addition in aqueous solution of Gd@C(60)(OH)(x) and Gd@C(60)[C(COOH(2))](10).

Authors:  Sabrina Laus; Balaji Sitharaman; Eva Tóth; Robert D Bolskar; Lothar Helm; Subashini Asokan; Michael S Wong; Lon J Wilson; André E Merbach
Journal:  J Am Chem Soc       Date:  2005-07-06       Impact factor: 15.419

7.  Water-structuring molecules and nanomaterials enhance radiofrequency heating in biologically relevant solutions.

Authors:  Nadia C Lara; Asad A Haider; Jason C Ho; Lon J Wilson; Andrew R Barron; Steven A Curley; Stuart J Corr
Journal:  Chem Commun (Camb)       Date:  2016-10-18       Impact factor: 6.222

8.  Highly efficient conversion of superoxide to oxygen using hydrophilic carbon clusters.

Authors:  Errol L G Samuel; Daniela C Marcano; Vladimir Berka; Brittany R Bitner; Gang Wu; Austin Potter; Roderic H Fabian; Robia G Pautler; Thomas A Kent; Ah-Lim Tsai; James M Tour
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-09       Impact factor: 11.205

9.  [Gd@C(82)(OH)(22)](n) nanoparticles induce dendritic cell maturation and activate Th1 immune responses.

Authors:  De Yang; Yuliang Zhao; Hua Guo; Yana Li; Poonam Tewary; Gengmei Xing; Wei Hou; Joost J Oppenheim; Ning Zhang
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

10.  Water-soluble fullerene (C60) derivatives as nonviral gene-delivery vectors.

Authors:  Balaji Sitharaman; Tatiana Y Zakharian; Anita Saraf; Preeti Misra; Jared Ashcroft; Su Pan; Quynh P Pham; Antonios G Mikos; Lon J Wilson; David A Engler
Journal:  Mol Pharm       Date:  2008-05-28       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.